Contact Us

Life Sciences

Introduction

Clinical trial sites deal with a myriad of tasks right from patient recruitment to capturing patient data and performing tests/procedures. In addition to facilitating patient interface, these sites also serve as the direct point of care for medical concerns. Sites have a direct impact on the enrollment rate, patient screening, patient retention, data quality, and compliance with regulations, and study protocol.

If a clinical trial fails to reach its enrollment target, the trial timeline would increase, resulting in extensive monetary losses, potentially budding the need for new sites. It is therefore paramount for clinical trial success to select a high-performing site with adequate outreach capacities, a physician network, and a promising local population demographic. A high-quality trial site consolidates the sponsor’s ROI along with the effective timeline of a novel drug’s patent.

Site selection in hindsight: Revolutionizing clinical trial optimization with AI

The conventional method used to select clinical trial sites relied on their experience in facilitating studies. However, this method deduced high historical participation as an indication of high enrollment potential, which isn’t always right. Such and similar loopholes in site optimization are being countered by modern technologies such as AI.

AI is now seen as the ultimate decision-making tool, enabling predictive models to anticipate future enrollment rates based on historical data. This includes enrollment duration, site activation time, and time to first patient in. Such predictive models help you identify and select the most resourceful, and relevant sites for your research. Real-time monitoring and forecasting of site performance further aid in the early detection of performance issues, supporting proactive decision-making.

The power of AI: Consolidating site performance and clinical trial success

AI is set to transform clinical trials with real-time insights for site optimization. Here is how AI helps –

  • Continuous capturing and assessment of enrollment data provide up-to-date information on enrollment progress and completion timelines.
  • Real-time monitoring enables simulated enrollment scenarios to accurately forecast enrollment rates and mitigate site performance discrepancies, regulatory challenges, and slow recruitment.
  • Automated data analysis, timely insights, and predictive analytics facilitate real-time site performance monitoring.
  • Advanced AI algorithms and models can effectively identify deviations from expected site performance trajectory and prompt resolution strategies.
  • Enrollment rate, enrollment target achievement, dropout rate, participant diversity, and other key performance metrics can be accurately tracked with AI.
  • AI-enabled real-time dashboards and reports offer a comprehensive overview to the relevant stakeholders of site performance.

TCG Digital’s site optimization solution powered by AI platform mcube™

TCG Digital’s site selection tool is powered by the AI engine of mcube™. It is designed to facilitate seamless site selection and enable clinical trial optimization.

Our approach focuses on –

  • Using a multi-objective optimization function for optimal site selection, keeping different criteria such as cost, quality, historical performance, and existence of KOLs.
  • Ensuring access to the subject population adhering to the eligibility criteria.
  • Identifying resource availability, technical facilities, and staff quality at sites.

The algorithm also uses business rules for faster and more efficient execution. This approach helps biopharmaceutical companies and researchers select the most suitable site for their clinical trials. Moreover, by providing the option of better sites, the site selection solution improves trial timelines and minimizes site-related costs.

Empowering future clinical trials with AI-enabled site optimization

More and more emphasis is being laid on choosing the most relevant, resourceful, and equipped clinical trial sites, in order to ensure the success of medical research. As a backbone, these sites play a multifunctional role and are detrimental to enhancing data quality and enrollment rates and ensuring compliance. Overcoming the limitations of traditional site selection techniques, TCG Digital’s AI-powered approach stands to revolutionize the process of site selection. With real-time insights into site performance, proactive decision-making is made easier, allowing for early issue resolution. AI algorithms, capable of continuously monitoring enrollment data offer substantial scope in performance optimization and maximizing return for sponsors.

 

Introduction

Flow cytometry is a formidable asset for a researcher. By compartmentalizing cells based on set molecular characteristics, flow cytometry provides information on specific cell types from highly complex and populated samples. This technique analyzes thousands of cells per second, allowing researchers to collect huge data volumes in a relatively short time.

Flow cytometry plays a crucial role in various fields such as cancer management aiding in early detection, determining treatment effectiveness, and enabling personalized therapy decisions. It also helps in screening new therapies faster, and cheaper. Flow cytometry is also widely used in various other applications like protein engineering, genomics, and vaccine development.

However, traditional flow cytometry workflows are often hindered by manual gating – a labor-intensive process where analysts visually assess scatter plots and histograms to draw regions around cell populations of interest – being prone to subjectivity and bias.

With the exponential growth of data and the complexity of cell populations, manual gating becomes increasingly impractical and difficult. Automated gating algorithms, powered by AI and ML, offer a solution to this challenge. By leveraging unsupervised and supervised approaches, these algorithms can efficiently identify cell populations of interest, reducing analysis time and minimizing bias.

TCG Digital’s innovative approach to flow cytometry combines AI/ML algorithms with advanced analytics, enabling the interpretation of high-dimensional data with unprecedented accuracy. By automating gating strategies and leveraging unsupervised and supervised techniques, TCG Digital’s platform streamlines workflow, enhances consistency, and accelerates biomarker discovery.

In addition to automated gating, AI and ML play a crucial role in data analysis and visualization. Advanced algorithms enable dimensionality reduction, cluster analysis, and cell identity interpretation, empowering researchers to extract meaningful insights from complex datasets. With advanced clustering algorithms such as Uniform Manifold Approximation (UMAP) and t-distributed Stochastic Neighbor Embedding (t-SNE), researchers can navigate high-dimensional data with ease, facilitating the discovery of novel cell types and biomarkers.

Other algorithms, such as self-organizing map (SOM) and PhenoGraph, can improve cluster discovery. Moreover, AI/ML tools can enhance cell identity interpretation through automated gating strategies, deployment of supervised algorithms, and identification of immunophenotypes and biomarkers. Furthermore, frequency tables, histograms, UMAP plots colored by cluster or relative marker expressions, contour plots, and tSNE plots (for cell subset visualizations) are showcasing immense opportunities for AI-powered flow cytometry data analysis.

Integrating AI/ML, leveraging novel algorithms, and harnessing the power of automation is proving to be groundbreaking for the life sciences industry. Advanced flow cytometry will be the cornerstone of this transformation, replacing manual gating with highly sophisticated, automated gating algorithms. Using innovative software solutions for flow cytometry, data analysis will not only bridge existing gaps and overcome subjectivity bias but will also efficiently deal with complex datasets and large cell populations to derive actionable insights. Auto-gating for cell sorting, automated cell population identification, cell development modeling, and dimensionality reduction are the highlights of computational flow cytometry. It will have a substantial impact on vaccine development, proteomics, protein engineering, drug development, and many more scientific areas.

Introduction

In a fast-paced world of research, laboratories face increasing pressure to innovate rapidly. Amidst this, data emerges as the ultimate tool, with big pharma companies leading the charge in utilizing AI-driven analytics for lab efficiency improvement.

Some of the challenges faced in ensuring optimal laboratory performance today include:

  • A myriad of data silos resulting in myopic decision making
  • Manual reporting processes that cause unnecessary overhead
  • Delayed reporting, which leads to missed opportunities

Laboratories are now moving towards replacing traditional performance analytics solutions with AI-enabled integrated solutions to facilitate both proactive and reactive decision-making, marking a paradigm shift in how laboratories operate.

Performance analytics labs: A centralized data-driven approach

Laboratories are realizing the significance of centralized data management with data lakes and warehouses as they help consolidate data acquired from lab software and instruments. A centralized, data-driven performance analytics approach leads to enhanced productivity, efficiency, and utilization, with a focus on reducing operational costs and procedural errors. Key Performance Indicators such as turn-around time, asset utilization, equipment downtime, consumable usage, and overall equipment effectiveness play a pivotal role in measuring lab performance.

As the number and complexity of KPIs grow, manually optimizing them and maximizing operational performance becomes challenging. AI-enabled analysis techniques are now being adopted to mitigate this challenge and ensure continuous improvement in lab KPIs, moving towards optimized lab performance.

The role of AI-enabled optimization techniques and ML in laboratories

Some areas where the implementation of AI-driven analysis techniques is already causing disruptions:

  1. Demand forecasting – Predictive analysis of historical data helps estimate and predict the demand for raw materials and consumables required in the lab, reducing procurement cycles and associated costs.
  2. Inventory management and optimization – Efficient demand forecasting results in efficient inventory management. Leveraging ML algorithms helps track consumable wastage and accurately identifies the factors causing it. This allows labs to take corrective actions, reduce inventory management costs, and ensure lab inventory optimization.
  3. Predictive maintenance for labs – AI can help identify anomalies in the expected performance and the potential downtime or chances of failure for lab instruments. This allows labs to plan for pre-emptive instrument maintenance and avoid operational outages caused by unplanned instrument downtime.

TCG Digital’s lab performance monitoring solution: Enhancing operational efficiency

TCG Digital’s laboratory performance monitoring solution provides a consolidated view of interconnected lab data by merging LIMS data with other sources like scientific data management systems (SDMS) or electronic lab notebooks (ELN). The performance dashboards provide insights into critical sample metrics like cost assessment, TAT, and on-time completion, enabling data-driven decision-making.

An assortment of solutions for lab analytics include:

The solution comprises of a rich library of laboratory KPIs that facilitate the following:

  • Analysis of on-time completion and turnaround time for all requests
  • Analysis of pending requests overdue and average delay statistics
  • Analysis of completed tests to track on-time deliveries by client/sample or other dimensions
  • Analysis of pending tests overdue and average delay statistics and trends
  • Analysis of billed/un-billed turnover costs – trends, distribution and drill-down
  • Cost analysis over invoicing item parameters – trends and drill-down
  • Analysis of timesheet data, time tracking, and charge-outs by employees
  • On-off specification count analysis
  • Defect analysis with root cause analysis

Reimagine your lab’s performance monitoring: Improve KPIs, and optimize performance

Performance optimization in research labs is crucial for optimal resource utilization, and cost reduction.

TCG Digital’s innovative solutions are empowering laboratories to navigate the complexities of modern research seamlessly, providing better insights into process performance and facilitating performance optimization. Embrace the future of lab excellence with TCG Digital’s AI-powered lab performance analytics solutions that not only offer a 360-degree view of lab operations but also provide transparency and better decision-making capabilities.

Want to know more about how to step up your lab performance? Write to us at contact@tcgdigital.com